Chantal Britt received her MA degree in translation from the University of Geneva in 1996. She worked 13 years as a financial and science journalist at Bloomberg News and Swissinfo.ch and 10 years in science communication for non-profit organisations in the fields of cancer research (SAKK), microbiology, infectious diseases (ESCMID), human toxicology (SCAHT), veterinary medicine (ENOVAT) and preclinical research (Swiss 3RCC). For three years she was responsible for communications at the European Society of Clinical Microbiology and Infectious Diseases and its congress. After falling sick with long covid in March 2020, Britt founded patient organisation Long Covid Switzerland, where she acts as president. She then joined network organisation Long COVID Europe where she currently is one of the co-Chairs. Since 2020 she has been active as a patient advocate and patient and public involvement expert in different roles. She holds PPI mandates in the assessment of research projects, helps promote PPI in clinical research projects and trains patients and researcher on patient engagement. She is a co-recipient of a seed grant for a citizen science project on long covid. In 2022, she joined the Competence Centre for Participatory Healthcare at the Bern University of Applied Sciences as a researcher in participatory healthcare. She is a board member at EUPATI Switzerland, a member of the patient advisory board at Swiss Patient Organisation SPO and used to be a working group leader at Veterinary AMR Network ENOVAT. Her interests are in participatory research, PPI and citizen science, Long Covid, ME/CFS, AMR, management of chronic and/or post-infectious diseases, gender medicine, and science communication.
